7th – 8th July 2023
EPO presents novel data on its HNSCC PDX models at the AACR-AHNS Head and Neck Cancer Congress in Montreal, QC, Canada
The American Association for Cancer Research (AACR) and the American Head and Neck Society (AHNS) host the third AACR-AHNS Joint Conference in Montreal, Canada, where EPO is also actively participating with a poster. This poster shows EPOs new data on its head and neck cancer PDX model panel regarding chemosensitivity testing, molecular characterization and HLA-matching analyses. We are happy to meet you at the poster to discuss our models and potential collaboration opportunities!
Poster: : New patient derived head and neck xenograft (PDX) for drug development, immune-oncology and translational research